Weight-Loss Program Aids African-American Breast Cancer Survivors

This article originally appeared here.
Share this content:
Weight-Loss Program Aids African-American Breast Cancer Survivors
Weight-Loss Program Aids African-American Breast Cancer Survivors

(HealthDay News) -- A community-based interventionist-guided weight-loss program is efficacious for early-stage African-American breast cancer survivors (AABCS), according to a study published online June 15 in the Journal of Clinical Oncology.

Melinda Stolley, Ph.D., from the Medical College of Wisconsin Cancer Center in Milwaukee, and colleagues examined the effect of a weight loss intervention for AABCS on weight, body composition, and behavior. Early-stage AABCS were randomized to a six-month interventionist-guided or self-guided weight loss program (125 and 121 participants, respectively), which supported changes to promote a 5 percent weight loss. At baseline, post-intervention (six months), and follow-up (12 months), the authors collected anthropometric, body composition, and behavioral data.

The researchers found that both groups lost weight; the mean and percentage of weight loss were greater in the guided group compared with the self-guided group (six months: 3.5 versus 1.3 kg and 3.6 versus 1.4 percent, respectively; both P < 0.001; 12 months: 2.7 versus 1.6 kg and 2.6 versus 1.6 percent, respectively; both P < 0.05). Overall, 44 and 19 percent of participants in the guided and self-guided groups met the goal of 5 percent weight loss. At both time points, the interventionist-guided group had greater body composition and behavioral changes.

"Affordable, accessible health promotion programs represent a critical resource for AABCS," the authors write.

One author disclosed ties to Watermark Research Partners.

Abstract
Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs